BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 15705182)

  • 1. Transforming growth factor-beta and Smad signalling in kidney diseases.
    Wang W; Koka V; Lan HY
    Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad3 as a mediator of the fibrotic response.
    Flanders KC
    Int J Exp Pathol; 2004 Apr; 85(2):47-64. PubMed ID: 15154911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SETD2 deficiency promotes renal fibrosis through the TGF-β/Smad signalling pathway in the absence of VHL.
    Liu C; Ni L; Li X; Rao H; Feng W; Zhu Y; Zhang W; Ma C; Xu Y; Gui L; Wang Z; Aji R; Xu J; Gao WQ; Li L
    Clin Transl Med; 2023 Nov; 13(11):e1468. PubMed ID: 37933774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin.
    Meng XM; Zhang Y; Huang XR; Ren GL; Li J; Lan HY
    Oncotarget; 2015 Nov; 6(35):36984-97. PubMed ID: 26474462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CaMKII Inhibitory Peptide AIP Alleviates Renal Fibrosis Through the TGF-
    Feng X; Zhang J; Yang R; Bai J; Deng B; Cheng L; Gao F; Xie J; Zhang B
    J Pharmacol Exp Ther; 2023 Sep; 386(3):310-322. PubMed ID: 37419684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling.
    Yuan Q; Ren Q; Li L; Tan H; Lu M; Tian Y; Huang L; Zhao B; Fu H; Hou FF; Zhou L; Liu Y
    Nat Commun; 2022 Jan; 13(1):438. PubMed ID: 35064106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-Beta as a Master Regulator of Diabetic Nephropathy.
    Wang L; Wang HL; Liu TT; Lan HY
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad linker region phosphorylation is a signalling pathway in its own right and not only a modulator of canonical TGF-β signalling.
    Kamato D; Do BH; Osman N; Ross BP; Mohamed R; Xu S; Little PJ
    Cell Mol Life Sci; 2020 Jan; 77(2):243-251. PubMed ID: 31407020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant therapy against TGF-β/SMAD pathway involved in organ fibrosis.
    Ghafouri-Fard S; Askari A; Shoorei H; Seify M; Koohestanidehaghi Y; Hussen BM; Taheri M; Samsami M
    J Cell Mol Med; 2024 Jan; 28(2):e18052. PubMed ID: 38041559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DACH1 attenuated PA-induced renal tubular injury through TLR4/MyD88/NF-κB and TGF-β/Smad signalling pathway.
    Lin J; Li B; Xu Q; Liu YS; Kang YL; Wang X; Wang Y; Lei Y; Bai YL; Li XM; Zhou J
    J Endocrinol Invest; 2024 Jun; 47(6):1531-1544. PubMed ID: 38147289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of estradiol and renin-angiotensin system with microRNAs-21 and -29 in renal fibrosis: focus on TGF-β/smad signaling pathway.
    Rajabi S; Saberi S; Najafipour H; Askaripour M; Rajizadeh MA; Shahraki S; Kazeminia S
    Mol Biol Rep; 2024 Jan; 51(1):137. PubMed ID: 38236310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β1/Smad Signalling in Proliferative Glomerulonephritis Associated with Autoimmune Diseases.
    Chalkia A; Gakiopoulou H; Theochari I; Foukas PG; Vassilopoulos D; Petras D
    Mediterr J Rheumatol; 2022 Jun; 33(2):176-184. PubMed ID: 36128207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1 signaling in kidney disease: From Smads to long non-coding RNAs.
    Tang PM; Tang PC; Chung JY; Lan HY
    Noncoding RNA Res; 2017 Mar; 2(1):68-73. PubMed ID: 30159422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into extracellular and post-translational regulation of TGF-β family signalling pathways.
    Shimmi O; Newfeld SJ
    J Biochem; 2013 Jul; 154(1):11-9. PubMed ID: 23698094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leonurine inhibits cardiomyocyte pyroptosis to attenuate cardiac fibrosis via the TGF-β/Smad2 signalling pathway.
    Li Z; Chen K; Zhu YZ
    PLoS One; 2022; 17(11):e0275258. PubMed ID: 36327230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.
    Toma I; McCaffrey TA
    Cell Tissue Res; 2012 Jan; 347(1):155-75. PubMed ID: 21626289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifaceted TGF-β signaling, a master regulator: From bench-to-bedside, intricacies, and complexities.
    Ahuja S; Zaheer S
    Cell Biol Int; 2024 Feb; 48(2):87-127. PubMed ID: 37859532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-octyl itaconate inhibits high glucose induced renal tubular epithelial cell fibrosis through TGF-β-ROS pathway.
    Zou X; Wu M; Tu M; Tan X; Long Y; Xu Y; Li M
    J Recept Signal Transduct Res; 2024 Apr; ():1-8. PubMed ID: 38660706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged Antibiotic Use in a Preclinical Model of Gulf War Chronic Multisymptom-Illness Causes Renal Fibrosis-like Pathology via Increased micro-RNA 21-Induced PTEN Inhibition That Is Correlated with Low Host
    Trivedi A; Bose D; Saha P; Roy S; More M; Skupsky J; Klimas NG; Chatterjee S
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2 X 7 receptor is a critical regulator of extracellular ATP-induced profibrotic genes expression in rat kidney: implication of transforming growth factor-β/Smad signaling pathway.
    Mounieb F; Abdel-Sattar SA; Balah A; Akool ES
    Purinergic Signal; 2023 Nov; ():. PubMed ID: 37934321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.